Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin

DUBLIN, Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment is the first and only non-surgical fat reduction technology to be FDA-cleared for improved appearance of lax ... Devices, Dermatology, FDA Allergan, CoolSculpting
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news